LIU YI 4
4 · Kura Oncology, Inc. · Filed Jan 26, 2018
Insider Transaction Report
Form 4
LIU YI
Chief Scientific Officer
Transactions
- Award
Option to purchase common stock
2018-01-24+43,000→ 43,000 totalExercise: $20.00Exp: 2028-01-23→ Common Stock (43,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments commencing on the grant date.